Prognostic value and characteristics of N1c colorectal cancer

The presence of tumour deposits (TDs) in colorectal cancer (CRC) is associated with poor prognosis. The seventh edition of TNM subclassified a new nodal stage, N1c, characterized by the presence of TDs without any concurrent positive lymph node (LN). It is not clear if the N1c category is or is not equal to LN metastasis. We aimed to examine the prevalence, characteristics and prognostic significance of this new subcategory.

[1]  H. Ueno,et al.  Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Fenghua Wang,et al.  The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy , 2016, Oncotarget.

[3]  E. Mayo,et al.  Prognostic value of tumour deposit and perineural invasion status in colorectal cancer patients: a SEER‐based population study , 2016, Histopathology.

[4]  P. Ding,et al.  Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy , 2015, Oncotarget.

[5]  M. Washington,et al.  The Impact of Tumor Deposits on Colonic Adenocarcinoma AJCC TNM Staging and Outcome , 2015, The American journal of surgical pathology.

[6]  H. Brenner,et al.  Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition. , 2014, European journal of cancer.

[7]  Joon-Oh Park,et al.  Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. , 2014, The Lancet. Oncology.

[8]  M. Washington,et al.  Tumor deposits in rectal adenocarcinoma after neoadjuvant chemoradiation are associated with poor prognosis , 2014, Modern Pathology.

[9]  R. Yantiss,et al.  Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma. , 2014, Archives of pathology & laboratory medicine.

[10]  Y. Oda,et al.  Tumor Deposit Is a Poor Prognostic Indicator for Patients Who Have Stage II and III Colorectal Cancer With Fewer Than 4 Lymph Node Metastases but not for Those With 4 or More , 2014, Diseases of the colon and rectum.

[11]  H. Ueno,et al.  Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. , 2014, American journal of surgery.

[12]  H. Ueno,et al.  Multicenter Study for Optimal Categorization of Extramural Tumor Deposits for Colorectal Cancer Staging , 2012, Annals of surgery.

[13]  Chengzhong Xing,et al.  Is the Seventh Edition of the UICC/AJCC TNM Staging System Reasonable for Patients With Tumor Deposits in Colorectal Cancer? , 2012, Annals of surgery.

[14]  A. Bateman,et al.  Colorectal cancer staging using TNM 7: is it time to use this new staging system? , 2012, Journal of Clinical Pathology.

[15]  J. Park,et al.  Is the N1c category of the new american joint committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy? , 2011, Cancer.

[16]  L. Påhlman,et al.  Lymph nodes, tumor deposits, and TNM: are we getting better? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. D. L. de Lange-de Klerk,et al.  Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III , 2010, Annals of Surgical Oncology.

[18]  R. Herrmann,et al.  Shape is not associated with the origin of pericolonic tumor deposits. , 2010, American journal of clinical pathology.

[19]  H. Ueno,et al.  Tumor deposits are encountered in advanced colorectal cancer and other adenocarcinomas: an expanded classification with implications for colorectal cancer staging system including a unifying concept of in-transit metastases , 2009, Modern Pathology.

[20]  I. Nagtegaal,et al.  Colorectal tumour deposits in the mesorectum and pericolon; a critical review , 2007, Histopathology.

[21]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[22]  A. Duval,et al.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.

[23]  N. Goldstein,et al.  Pericolonic tumor deposits in patients with T3N+M0 colon adenocarcinomas , 2000 .

[24]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[25]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.

[26]  W. B. Gabriel,et al.  Lymphatic spread in cancer of the rectum , 1935 .